Clinical Trial Update: Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis [Phase 2]

View source ↗

Summary

Phase 2 randomized stepped-wedge trial evaluating emapalumab for enteritis in Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
• Enteritis

Drugs mentioned

• GAMIFANT (emapalumab-lzsg)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis | Phase 2 | Status: RECRUITING